Gujarat Themis Biosyn Limited: Disclosure under SEBI Takeover Regulations
Disclosure under SEBI Takeover Regulations - PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED has submitted to the Exchange a copy of Disclosure under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
SectorIndustrials
Sources
- NSE filing - Gujarat Themis Biosyn Limited · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Rajani Associates advises Wanbury on ₹205 crore redemption of debentures31 Aug 2026 · ₹205 cr
- Cyril Amarchand Mangaldas, Khaitan & Co act on Horizon Industrial Parks ₹2,600 crore IPO31 Aug 2026 · ₹2,600 cr
- CMS INDUSLAW, SAM, TT&A, CAM act on Yulu Bikes $93 million Series C fundraise31 Aug 2026 · $93 mn
- Piramal Finance Limited: Press Release31 Aug 2026 · ₹3,850 cr
- Welspun Living Limited: General Updates31 Aug 2026
- Tribhovandas Bhimji Zaveri Limited: Public Announcement-Open Offer31 Aug 2026